Drugs / Na-GST-1

Trials 8 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 17 trials
Phase 1 NCT03373214 Feb 2018 → Feb 2019 hookworm infectious disease Baylor College of Medicine Completed No outcome recorded
Phase 1 NCT02839161 Jan 2017 → Dec 2018 hookworm infectious disease Baylor College of Medicine Completed No outcome recorded
Phase 1 NCT02476773 Jan 2016 → Jun 2017 hookworm infectious disease Baylor College of Medicine Completed No outcome recorded
Phase 1 NCT02126462 Nov 2014 → Feb 2016 hookworm infectious disease Baylor College of Medicine Completed No outcome recorded
Phase 1 NCT02143518 Oct 2014 → Jun 2016 hookworm infectious disease Baylor College of Medicine Completed No outcome recorded
Phase 1 NCT01385189 May 2012 → Jan 2015 hookworm infectious disease Baylor College of Medicine Completed No outcome recorded
Phase 1 NCT01261130 Nov 2011 → Aug 2014 hookworm infectious disease Baylor College of Medicine Completed No outcome recorded
Phase 21 trial
Phase 2 NCT03172975 Mar 2018 → Dec 2024 hookworm infectious disease Baylor College of Medicine Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 10 sources stand behind the page.

FieldValueCited text
Known as Na-GST-1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01385189
7

NCT01261130

NCT02126462

NCT03172975

NCT02476773

NCT02143518

NCT02839161

NCT03373214

Known as N americanus glutathione S-transferase-1 “Necator americanus aspartic protease-1 (Na-APR-1) and N americanus glutathione S-transferase-1 (Na-GST-1) are involved in the digestion and detoxification of haemoglobin in the...” PMID 32926834 Sep 2020
Known as Necator americanus Glutathione-S-Transferase-1 Necator americanus Glutathione-S-Transferase-1 (Na-GST-1) plays a role in the digestion of host hemoglobin by adult N. americanus hookworms.” PMID 28464026 May 2017
Modality Protein / enzyme biologic “The Na-GST-1 vaccine formulations to be tested in this study consist of the 24 kDa recombinant protein Na-GST-1 adsorbed to Alhydrogel® either with or without the addition of GLA-AF.” NCT01261130
Route Intramuscular “Vaccinations were administered via intramuscular injection on days 0, 56, and 112.” PMID 28464026 May 2017